San Francisco, CA, United States of America

Eric Q Parkhill

This inventor holds 28 USPTO granted patents and 8 published patent applications, plus 5 CIPO patents and 18 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Gilead Sciences, Inc., Gilead Palo Alto, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric Q Parkhill. Retrieved from https://idiyas.com/inventor/eric-q-parkhill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 28 (Patent Applications = 8)

% Patents Active = 89.3

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 18 (Patent Applications = 20)

Average Co-Inventor Count = 10.0

ph-index = 7

Forward Citations = 150(Granted Patents)

Location History:

Union City, CA (US) (2021 - 2022)
San Francisco, CA (US) (2010 - 2023)

Company Filing History:

25 out of 950

Gilead Sciences, Inc.

patents

3 out of 15

Gilead Palo Alto, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

PD-1 Inhibitors

Heterocyclic Compounds

Imidazopyrimidine Derivatives

Fused Heterocyclic Compounds

Ion Channel Modulators

Stearoyl CoA Desaturase Inhibitors

Therapeutic Compounds

Pyrido Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12590062 - PD-1/PD-L1 inhibitors (2026-03-31),

2. 12338233 - PD-1/Pd-L1 inhibitors (2025-06-24),

3. 11555029 - PD-1/PD-L1 inhibitors (2023-01-17),

4. 11236085 - PD-1/PD-L1 inhibitors (2022-02-01),

5. 11229638 - Therapeutic heterocyclic compounds (2022-01-25),

6. 11179397 - Imidazopyrimidine derivatives (2021-11-23),

7. 11040033 - Therapeutic heterocyclic compounds (2021-06-22),

8. 10899735 - PD-1/PD-L1 inhibitors (2021-01-26),

9. 10710986 - PD-1/PD-L1 inhibitors (2020-07-14),

10. 10100058 - Fused heterocyclic compounds as CaM kinase inhibitors (2018-10-16),

11. 9695192 - Fused heterocyclic compounds as ion channel modulators (2017-07-04),

12. 9682998 - Fused heterocyclic compounds as ion channel modulators (2017-06-20),

13. 9676760 - Fused heterocyclic compounds as ion channel modulators (2017-06-13),

14. 9598435 - Fused heterocyclic compounds as ion channel modulators (2017-03-21),

15. 9403782 - Fused heterocyclic compounds as ion channel modulators (2016-08-02),

Title: Inventor Eric Q Parkhill - Revolutionizing Technology

Introduction: Eric Q Parkhill is a visionary inventor based in San Francisco, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Eric Q Parkhill holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Eric Q Parkhill has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Throughout his career, Eric Q Parkhill has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eric Q Parkhill's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field of inventions, inspiring the next generation of inventors to dream big and create a better future.

Profile summary based on public USPTO records.